Pneumococcal Nasopharyngeal Carriage in Infants of Mothers Immunized with 23V Non-conjugate Pneumococcal Polysaccharide Vaccine

被引：9

作者：

Lopes, Claudia C. ^{[1
]}

Berezin, Eitan N. ^{[1
]}

Scheffer, Daniel ^{[2
]}

Huziwara, Rosana ^{[1
]}

Sliva, Maria I. ^{[1
]}

Brandao, Angela ^{[3
]}

Guerra, Maria L. ^{[3
]}

Brandileone, Maria C. ^{[3
]}

机构：

[1] Fac Ciencias Med Santa Casa Sao Paulo, Dept Pediat, Sao Paulo, Brazil

[2] Fac Ciencias Med Santa Casa Sao Paulo, Dept Social Med, Sao Paulo, Brazil

[3] Adolfo Lutz Inst, Sao Paulo, Brazil

来源：

JOURNAL OF TROPICAL PEDIATRICS | 2012年 / 58卷 / 05期

关键词：

Streptococcus pneumoniae; 23 valent pneumococcal polysaccharide vaccine; pneumococcal serotypes; SEROTYPE-SPECIFIC HYPORESPONSIVENESS; MATERNAL IMMUNIZATION; COLONIZATION; EPIDEMIOLOGY; DISEASE;

D O I：

10.1093/tropej/fmr107

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

To assess the effects of maternal immunization on pneumococcal colonization in infants, pregnant women were assigned into three groups. The group Pregn Vac received the Pn23V during pregnancy, the group Puerp Vac received vaccine during immediate puerperium and the group No Vac received no vaccine. Nasopharyngeal samples were collected at 3 and 6 months. A total of 150 pregnant women were selected during the prenatal period. The proportion of pneumococcal carriage in at least one evaluation was in group Pregn Vac 22.2% (10/45), group Puerp Vac 23.4% (11/47) and group No Vac 21.2% (10/47), respectively. The most frequently isolated serotype in group Puerp Va and group No Vac was 6B and 6A. In the Pregn Vac, the most important serotype was 19F. Although this study was unable to demonstrate any effect of maternal vaccination in reducing pneumococcal colonization, reduction of colonization for serotype 6B in infants may be an important effect.

引用

页码：348 / 352

页数：5

共 50 条

[21] Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia
Desai, Ankita P.
Sharma, Dolly
Crispell, Emily K.
Baughman, Wendy
Thomas, Stepy
Tunali, Amy
Sherwood, Logan
Zmitrovich, April
Jerris, Robert
Satola, Sarah W.
Beall, Bernard
Moore, Matthew R.
Jain, Shabnam
Farley, Monica M.
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (11) : 1168 - 1174
[22] Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine compared to a 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults
Jackson, Lisa A.
Gurtman, Alejandra
van Cleeff, Martin
Jansen, Kathrin U.
Jayawardene, Deepthi
Devlin, Carmel
Scott, Daniel A.
Emini, Emilio A.
Gruber, William C.
Schmoele-Thoma, Beate
VACCINE, 2013, 31 (35) : 3577 - 3584
[23] Nasopharyngeal S. pneumoniae carriage and density in Belgian infants after 9 years of pneumococcal conjugate vaccine programme
Wouters, Ine
Van Heirstraeten, Liesbet
Desmet, Stefanie
Blaizot, Stephanie
Verhaegen, Jan
Goossens, Herman
Van Damme, Pierre
Malhotra-Kumar, Surbhi
Theeten, Heidi
VACCINE, 2018, 36 (01) : 15 - 22
[24] Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children
Jayasinghe, Sanjay
Chiu, Clayton
Menzies, Rob
Lehmann, Deborah
Cook, Heather
Giele, Carolien
Krause, Vicki
McIntyre, Peter
VACCINE, 2015, 33 (48) : 6666 - 6674
[25] Systematic Review of the Effect of Pneumococcal Conjugate Vaccine Dosing Schedules on Vaccine-type Nasopharyngeal Carriage
Fleming-Dutra, Katherine E.
Conklin, Laura
Loo, Jennifer D.
Knoll, Maria Deloria
Park, Daniel E.
Kirk, Jennifer
Goldblatt, David
Whitney, Cynthia G.
O'Brien, Katherine L.
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 : S152 - S160
[26] Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial
Thompson, Allison R.
Klein, Nicola P.
Downey, H. Jackson
Patterson, Scott
Sundaraiyer, Vani
Watson, Wendy
Clarke, Keri
Jansen, Kathrin U.
Sebastian, Shite
Gruber, William C.
Scott, Daniel A.
Schmoeele-Thoma, Beate
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (02) : 444 - 451
[27] Pilot trial of a pentavalent pneumococcal polysaccharide/protein conjugate vaccine in Gambian infants
Leach, A
Ceesay, SJ
Banya, WAS
Greenwood, BM
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (04) : 333 - 339
[28] Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study
Hammitt, Laura L.
Etyang, Anthony O.
Morpeth, Susan C.
Ojal, John
Mutuku, Alex
Mturi, Neema
Moisi, Jennifer C.
Adetifa, Ifedayo M.
Karani, Angela
Akech, Donald O.
Otiende, Mark
Bwanaali, Tahreni
Wafula, Jackline
Mataza, Christine
Mumbo, Edward
Tabu, Collins
Knoll, Maria Deloria
Bauni, Evasius
Marsh, Kevin
Williams, Thomas N.
Kamau, Tatu
Sharif, Shahnaaz K.
Levine, Orin S.
Scott, J. Anthony G.
LANCET, 2019, 393 (10186): : 2146 - 2154
[29] Persistence of Nasopharyngeal Pneumococcal Vaccine Serotypes and Increase of Nonvaccine Serotypes Among Vaccinated Infants and Their Mothers 5 Years After Introduction of Pneumococcal Conjugate Vaccine 13 in The Gambia
Usuf, Effua
Bottomley, Christian
Bojang, Ebrima
Cox, Isatou
Bojang, Abdoulie
Gladstone, Rebecca
Kampmann, Beate
Hill, Philip C.
Roca, Anna
CLINICAL INFECTIOUS DISEASES, 2019, 68 (09) : 1512 - 1521
[30] Pneumococcal Carriage in Infants Following Maternal Immunization with Pneumococcal Vaccine or Hemophilus influenzae type b Conjugate Vaccine During Pregnancy † 831
Janet A Englund
Coni C Cheesman
Edward O Mason
Claudia A Kozinetz
W P Glezen
Pediatric Research, 1998, 43 (Suppl 4) : 144 - 144

← 1 2 3 4 5 →